- Home
- TTI vs ORGO Comparison
TTI vs ORGO Comparison
Compare TTI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTI
- ORGO
- Stock Information
- Founded
- TTI 1981
- ORGO 1985
- Country
- TTI United States
- ORGO United States
- Employees
- TTI N/A
- ORGO N/A
- Industry
- TTI Oil & Gas Production
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- TTI Energy
- ORGO Health Care
- Exchange
- TTI Nasdaq
- ORGO Nasdaq
- Market Cap
- TTI 497.7M
- ORGO 465.6M
- IPO Year
- TTI 1990
- ORGO N/A
- Fundamental
- Price
- TTI $3.54
- ORGO $4.78
- Analyst Decision
- TTI Strong Buy
- ORGO Buy
- Analyst Count
- TTI 2
- ORGO 2
- Target Price
- TTI $5.00
- ORGO $6.50
- AVG Volume (30 Days)
- TTI 1.6M
- ORGO 993.4K
- Earning Date
- TTI 07-29-2025
- ORGO 08-07-2025
- Dividend Yield
- TTI N/A
- ORGO N/A
- EPS Growth
- TTI 426.72
- ORGO N/A
- EPS
- TTI 0.84
- ORGO N/A
- Revenue
- TTI $605,279,000.00
- ORGO $458,760,000.00
- Revenue This Year
- TTI $2.67
- ORGO $1.10
- Revenue Next Year
- TTI $7.55
- ORGO $9.93
- P/E Ratio
- TTI $4.21
- ORGO N/A
- Revenue Growth
- TTI N/A
- ORGO 5.35
- 52 Week Low
- TTI $2.03
- ORGO $2.28
- 52 Week High
- TTI $5.12
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- TTI 53.11
- ORGO 63.60
- Support Level
- TTI $3.17
- ORGO $4.30
- Resistance Level
- TTI $3.45
- ORGO $4.53
- Average True Range (ATR)
- TTI 0.17
- ORGO 0.26
- MACD
- TTI -0.03
- ORGO 0.02
- Stochastic Oscillator
- TTI 56.25
- ORGO 89.71
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.